Picture of vTv Therapeutics logo

VTVT — vTv Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

vTv Therapeutics up on $10 mln investment by CinRx Pharma

** Shares of vTv Therapeutics Inc  VTVT.O  up 13% at 81
cents premarket, above their 150-day moving average price of 72
cents
    ** VTVT says CinRx Pharma to invest $10 million to acquire
4.2 million of VTVT shares at $2.41/shr, a more than 200%
premium to stock's last closing price  urn:newsml:reuters.com:*:nGNX4sZrlR   
    ** Says investment brings a partner to help speed up
development of its treatment, TTP399, for diabetes patients
    ** As of Friday's closing price, stock had fallen 27.7% this
year

 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))

Recent news on vTv Therapeutics

See all news